Regulatory › Drugs@FDA › History › NDA209637 Drugs@FDA application timeline
NDA209637 14 dated FDA-coded AP submissions from 2017-12-05 through 2026-06-01, connected to 16 source-defined action assignments and 33 official document links.
14 Dated AP submissions
16 Action assignments
33 Official documents
0 Exact enforcement reports
1 Reviewed profile mappings
Reporting boundary This history reports exact Drugs@FDA submission status dates, source-defined action labels, and official document metadata for applications already selected by PeptideScanner. FDA's AP code and action labels are source metadata; this page does not interpret approval scope, reproduce document text, establish safety or effectiveness, or provide medical guidance. Document links open FDA-hosted material; PeptideScanner does not copy or summarize their contents.
Reviewed identity mapping
Connected peptide profiles Newest first
Submission and document chronology 14 submissions 2026-06-01 · status AP
Supplement 38 FDA action labels Labeling-Package Insert
2 official documents Label ↗ 2026-06-10 · FDA document 86202 Letter ↗ 2026-06-02 · FDA document 86129 2025-10-14 · status AP
Supplement 37 FDA action labels Labeling-Package Insert
4 official documents 2025-10-14 · status AP
Supplement 35 FDA action labels Labeling-Package Insert
3 official documents Review ↗ 2026-02-24 · FDA document 85119 Label ↗ 2025-10-15 · FDA document 83781 Letter ↗ 2025-10-15 · FDA document 83775 2025-01-28 · status AP
Supplement 25 FDA action labels Efficacy-New Indication
2 official documents Letter ↗ 2025-02-07 · FDA document 81169 Label ↗ 2025-02-05 · FDA document 80998 2024-11-01 · status AP
Supplement 32 FDA action labels Labeling-Medication Guide · Labeling-Package Insert
3 official documents Review ↗ 2026-02-24 · FDA document 85118 Label ↗ 2024-11-05 · FDA document 80142 Letter ↗ 2024-11-05 · FDA document 80127 2023-09-22 · status AP
Supplement 21 FDA action labels Labeling-Package Insert
2 official documents Label ↗ 2023-09-25 · FDA document 75555 Letter ↗ 2023-09-25 · FDA document 75551 2023-09-22 · status AP
Supplement 20 FDA action labels Labeling-Package Insert
2 official documents Label ↗ 2023-09-25 · FDA document 75556 Letter ↗ 2023-09-25 · FDA document 75550 2022-10-06 · status AP
Supplement 12 FDA action labels Labeling-Container/Carton Labels · Labeling-Package Insert
2 official documents Label ↗ 2022-10-11 · FDA document 72295 Letter ↗ 2022-10-07 · FDA document 72275 2022-03-28 · status AP
Supplement 9 FDA action labels Efficacy-New Dosing Regimen
2 official documents Label ↗ 2022-03-29 · FDA document 70644 Letter ↗ 2022-03-29 · FDA document 70639 2021-04-12 · status AP
Supplement 8 FDA action labels Labeling-Package Insert
2 official documents Label ↗ 2021-04-14 · FDA document 67060 Letter ↗ 2021-04-13 · FDA document 67048 2020-01-16 · status AP
Supplement 3 FDA action labels Efficacy-New Indication
2 official documents Letter ↗ 2020-01-17 · FDA document 61599 Label ↗ 2020-01-17 · FDA document 61593 2019-11-27 · status AP
Supplement 4 FDA action labels Labeling-Container/Carton Labels · Labeling-Package Insert
2 official documents Label ↗ 2019-12-02 · FDA document 61112 Letter ↗ 2019-11-29 · FDA document 61094 2019-04-09 · status AP
Supplement 1 FDA action labels Labeling-Container/Carton Labels
2 official documents Letter ↗ 2019-04-11 · FDA document 58289 Label ↗ 2019-04-10 · FDA document 58271 2017-12-05 · status AP
Original submission 1 No source action-type assignment was retained for this submission.
3 official documents Review ↗ 2018-01-16 · FDA document 51050 Letter ↗ 2017-12-07 · FDA document 50623 Label ↗ 2017-12-06 · FDA document 50622 Source archive dated 2026-08-24; observed 2026-08-24T21:23:49.000Z; reviewed 2026-08-24. Observation SHA-256: 6166fd223ef126a19e8ebfdaafe1fbf7c330a4cf7153cef00fb6c52c45ef757b.